Search Results

Pharm Country

Starton Therapeutics: Announcing Name Change for ChemioCare Inc

ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, today announced it has changed the name of the Company to Starton Therapeutics, Inc.

December 26, 2019

·

2 min read

Business

ChemioCare Announces Addition of Three Experienced Team Members

ChemioCare USA Inc. announced a strengthening of its Board and Management team.

August 3, 2018

·

4 min read

Drug Development

ChemioCare Completes Successful Human Bioavailability Study for Novel 7-Day Olanzapine Transdermal Delivery SystemPARP inhibitor induced nausea and vomiting program is now clinically ready to advance to Phase 3

ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, today announced the completion of a human bioavailability study of CMIO-OLNZ, a 7-day matrix transdermal delivery system of olanzapine for the treatment of poly ADP ribose polymerase (PARP) inhibitor induced nausea and vomiting (PIINV) (the “Study”).

December 18, 2019

·

4 min read